Institute of Neuroscience and Physiology, Department of Neurology, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.
J Neuroimmunol. 2011 Jun;235(1-2):98-103. doi: 10.1016/j.jneuroim.2011.04.002. Epub 2011 May 7.
High occurrence of measles, rubella and varicella zoster antibodies has been used as a biomarker for MS (the MRZ test). We analyzed measles antibody titres with respect to measles infection/measles vaccination status in 166 patients with MS or clinically isolated syndrome. Fifty blood donors served as controls. Measles vaccination yielded CSF measles antibodies in fewer patients (62%) than measles infection did (87%, p=0.001) and yielded lower measles titres in both serum and CSF (p<0.001). Controls had lower CSF measles titres than patients with measles vaccination alone (p<0.001). Childhood vaccinations probably reduce the sensitivity of the MRZ diagnostic test for MS.
麻疹、风疹和水痘带状疱疹抗体的高发生率已被用作多发性硬化症(MS)的生物标志物(MRZ 检测)。我们分析了 166 例 MS 或临床孤立综合征患者的麻疹抗体滴度与麻疹感染/麻疹疫苗接种状态的关系。50 名献血者作为对照。与麻疹感染(87%)相比,麻疹疫苗接种在较少的患者中产生 CSF 麻疹抗体(62%),并且在血清和 CSF 中产生的麻疹抗体滴度均较低(p<0.001)。对照组的 CSF 麻疹抗体滴度低于仅接受麻疹疫苗接种的患者(p<0.001)。儿童疫苗接种可能会降低 MRZ 检测对 MS 的诊断敏感性。